Cargando…

Supporting the management of type 2 diabetes with pharmacist-led reviews: an observational analysis

OBJECTIVE: Describe and assess the impact of a pharmacist-led patient review programme on the management and control of type 2 diabetes (T2D). DESIGN: Uncontrolled prospective cohort study with before and after intervention data collection. SETTING: General practices within NHS Slough Clinical Commi...

Descripción completa

Detalles Bibliográficos
Autores principales: Langran, Tim, Nanda, Nithya, Bataveljic, Attia, Gonzalez-Durio, Javier
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5353282/
https://www.ncbi.nlm.nih.gov/pubmed/28259852
http://dx.doi.org/10.1136/bmjopen-2016-013451
_version_ 1782515079155023872
author Langran, Tim
Nanda, Nithya
Bataveljic, Attia
Gonzalez-Durio, Javier
author_facet Langran, Tim
Nanda, Nithya
Bataveljic, Attia
Gonzalez-Durio, Javier
author_sort Langran, Tim
collection PubMed
description OBJECTIVE: Describe and assess the impact of a pharmacist-led patient review programme on the management and control of type 2 diabetes (T2D). DESIGN: Uncontrolled prospective cohort study with before and after intervention data collection. SETTING: General practices within NHS Slough Clinical Commissioning Group (CCG). PARTICIPANTS: 5910 patients with T2D. INTERVENTIONS: Pharmacists reviewed 5910 patients and worked with general practice teams to schedule any of the 9 key care processes recommended by the National Institute for Health and Care Excellence (NICE) that the patients were lacking, to optimise medication and to make other interventions such as providing lifestyle advice. MAIN OUTCOME MEASURES: The proportion of patients receiving the NICE-recommended 9 key care processes and proportion of patients whose glycated haemoglobin (HbA1c), blood pressure (BP) or total cholesterol (TC) readings were over target before and after the intervention period. RESULTS: The proportion of patients receiving all of the NICE-recommended 9 key care processes increased from 46% at project outset in April 2013 to 58% on completion in April 2014 and the percentage of patients achieving HbA1c, BP and TC targets all increased (65% to 70%, 70% to 76%, 78% to 82%, respectively). Quality Outcomes Framework (QOF) data for Slough CCG showed the percentage of diabetic patients achieving target HbA1c, BP and TC readings increased from April 2013 to April 2014, but then diminished in the year after project completion. CONCLUSIONS: The pharmacist-led review increased the number of key care processes administered and improved diabetic control during the year of programme delivery. The improvement abated during the year after, suggesting that such programmes should be ongoing rather than fixed term. The programme combined the strategic drive and project facilitation skills of Slough CCG, the general practice teams' knowledge of their patients and the clinical and information technology skills of an experienced pharmacist team.
format Online
Article
Text
id pubmed-5353282
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher BMJ Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-53532822017-03-17 Supporting the management of type 2 diabetes with pharmacist-led reviews: an observational analysis Langran, Tim Nanda, Nithya Bataveljic, Attia Gonzalez-Durio, Javier BMJ Open Diabetes and Endocrinology OBJECTIVE: Describe and assess the impact of a pharmacist-led patient review programme on the management and control of type 2 diabetes (T2D). DESIGN: Uncontrolled prospective cohort study with before and after intervention data collection. SETTING: General practices within NHS Slough Clinical Commissioning Group (CCG). PARTICIPANTS: 5910 patients with T2D. INTERVENTIONS: Pharmacists reviewed 5910 patients and worked with general practice teams to schedule any of the 9 key care processes recommended by the National Institute for Health and Care Excellence (NICE) that the patients were lacking, to optimise medication and to make other interventions such as providing lifestyle advice. MAIN OUTCOME MEASURES: The proportion of patients receiving the NICE-recommended 9 key care processes and proportion of patients whose glycated haemoglobin (HbA1c), blood pressure (BP) or total cholesterol (TC) readings were over target before and after the intervention period. RESULTS: The proportion of patients receiving all of the NICE-recommended 9 key care processes increased from 46% at project outset in April 2013 to 58% on completion in April 2014 and the percentage of patients achieving HbA1c, BP and TC targets all increased (65% to 70%, 70% to 76%, 78% to 82%, respectively). Quality Outcomes Framework (QOF) data for Slough CCG showed the percentage of diabetic patients achieving target HbA1c, BP and TC readings increased from April 2013 to April 2014, but then diminished in the year after project completion. CONCLUSIONS: The pharmacist-led review increased the number of key care processes administered and improved diabetic control during the year of programme delivery. The improvement abated during the year after, suggesting that such programmes should be ongoing rather than fixed term. The programme combined the strategic drive and project facilitation skills of Slough CCG, the general practice teams' knowledge of their patients and the clinical and information technology skills of an experienced pharmacist team. BMJ Publishing Group 2017-03-03 /pmc/articles/PMC5353282/ /pubmed/28259852 http://dx.doi.org/10.1136/bmjopen-2016-013451 Text en Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/ This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
spellingShingle Diabetes and Endocrinology
Langran, Tim
Nanda, Nithya
Bataveljic, Attia
Gonzalez-Durio, Javier
Supporting the management of type 2 diabetes with pharmacist-led reviews: an observational analysis
title Supporting the management of type 2 diabetes with pharmacist-led reviews: an observational analysis
title_full Supporting the management of type 2 diabetes with pharmacist-led reviews: an observational analysis
title_fullStr Supporting the management of type 2 diabetes with pharmacist-led reviews: an observational analysis
title_full_unstemmed Supporting the management of type 2 diabetes with pharmacist-led reviews: an observational analysis
title_short Supporting the management of type 2 diabetes with pharmacist-led reviews: an observational analysis
title_sort supporting the management of type 2 diabetes with pharmacist-led reviews: an observational analysis
topic Diabetes and Endocrinology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5353282/
https://www.ncbi.nlm.nih.gov/pubmed/28259852
http://dx.doi.org/10.1136/bmjopen-2016-013451
work_keys_str_mv AT langrantim supportingthemanagementoftype2diabeteswithpharmacistledreviewsanobservationalanalysis
AT nandanithya supportingthemanagementoftype2diabeteswithpharmacistledreviewsanobservationalanalysis
AT bataveljicattia supportingthemanagementoftype2diabeteswithpharmacistledreviewsanobservationalanalysis
AT gonzalezduriojavier supportingthemanagementoftype2diabeteswithpharmacistledreviewsanobservationalanalysis